Bluechiip listed on the ASX in June 2011. Since then, we have significantly developed our technology. Today it has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation. Bluechiip: Delivering confidence in every sample.
Bluechiip understands that every biological sample – stem cells, blood, eggs, sperm and other biospecimens – is critical, so our objective is to manage each one with optimal quality in the most efficient way.
Bluechiip’s advanced sample management solution is the only one that provides sample temperature with ID in cryogenic environments, driving productivity and improving quality. Bluechiip’s solution delivers confidence in every sample.
Corporate Presentation
Research notes
MST Access Research Report - 07 May 2024
MST Access Research Report - 13 Dec 2023
MST Access Research Report - 16th Aug 2023
MST Access Research Report - 22nd May 2023
MST Access Research Report - 16th May 2023
MST Access Research Report - 4th April 2023
Reports
Download Bluechiip’s most recent Annual and Quarterly reports from the links below: